AOD 9604 5mg

Description

AOD 9604 is a synthetic peptide derived from a specific fragment of human growth hormone (hGH). It corresponds to the 176–191 amino acid sequence of the growth hormone molecule and is commonly referred to as GH Fragment 176–191. The peptide also includes a modified tyrosine residue at the N-terminus, which researchers believe may improve structural stability.

AOD 9604 was originally developed as a modified growth hormone fragment designed for research related to metabolic processes and fat metabolism. Because it represents only a small section of the larger growth hormone molecule, it is often studied independently to examine how specific regions of hGH may influence biological pathways.

Overview

AOD 9604 was first developed during the 1990s as part of research focused on identifying protein fragments that might influence lipid metabolism and body fat regulation. Scientific investigations have since explored the peptide’s potential involvement in lipolysis, the biological process in which stored triglycerides within fat cells are broken down into glycerol and free fatty acids, which can then be used as an energy source by the body.

Laboratory studies have suggested that AOD 9604 may influence lipolytic signaling pathways within adipose (fat) tissue. Enzymes such as lipases, which are responsible for breaking down stored fats, are central to this process. Experimental models have examined whether the peptide may affect the activity or sensitivity of these metabolic pathways.

Some research has also explored a possible interaction between AOD 9604 and the beta-adrenergic receptor system, particularly the beta-3 adrenergic receptors (β3-AR) found in fat cells. These receptors are associated with the regulation of fat metabolism. In certain experimental studies, the presence of AOD 9604 was associated with increased expression of β3-AR RNA, suggesting that the peptide may influence the responsiveness of lipolytic receptors involved in fat metabolism.

Because AOD 9604 represents only a small fragment of the full growth hormone molecule, researchers have proposed that it may affect fat metabolism pathways without stimulating some of the broader hormonal effects commonly associated with natural growth hormone signaling, such as increased Insulin-like Growth Factor-1 (IGF-1) production.

Ongoing research continues to investigate the potential biological mechanisms of AOD 9604, particularly in relation to metabolic regulation and lipid metabolism.

Reference

https://pubmed.ncbi.nlm.nih.gov/?term=AOD+9604

• • • • • • • • • • • • • • •  PLEASE READ • • • • • • • • • • • • • • •

RESEARCH USE ONLY DISCLAIMER AND LIMITATION OF LIABILITY

All articles, materials, content, and product-related information made available on this website are provided strictly for informational and educational purposes only and shall not be construed as medical, pharmaceutical, clinical, or therapeutic advice, nor as a representation of safety or efficacy for any human or animal use.

These products are not drugs, pharmaceuticals, biologics, medical devices, dietary supplements, food products, or cosmetics, and they have not been evaluated, approved, or authorized by the United States Food and Drug Administration (FDA) or any other regulatory authority for human or animal use.

The Company reserves all rights and expressly disclaims any liability arising from misuse, improper handling, or unauthorized application of its products.